1. Market Research
  2. > Pathology
Customer Support

Talk to Sam

+1 646 893 5945

About 12000 reports for Lymphoma (page 1)

Download Unlimited Documents from Trusted Public Sources

View report >

Lymphoma Statistics in the UK

  • January 2018
  • 6 pages

(observed and ##. ##% five years from a lymphoma diagnosis in 2009-2013.

  • Cancer
  • Lymphoma
  • United Kingdom
  • Demographic
View report >

Lymphoma Statistics

  • December 2019
  • 11 pages

Survival of patients with Burkitt lymphoma by sex.

  • Cancer
  • Lymphoma
  • Pathology
  • Germany
  • United States
View report >

Lymphoma Statistics

  • December 2019
  • 12 pages

Survival of patients with Non-follic. lymphoma by sex.

  • Cancer
  • Lymphoma
  • Pathology
  • Germany
  • United States
View report >

Lymphoma Statistics

  • December 2019
  • 12 pages

Survival of patients with Follic. lymphoma by sex.

  • Cancer
  • Lymphoma
  • Pathology
  • Germany
  • United States
View report >

Lymphoma Statistics

  • December 2019
  • 13 pages

Survival of patients with MALT lymphoma by sex.

  • Cancer
  • Lymphoma
  • Pathology
  • Germany
  • United States
View report >

Therapy Market in Washington (USA)

  • November 2019
  • 12 pages

Lymphoma is a diverse group of cancers that originate from B-, T- or NK- cells.

  • Lymphoma
  • Pathology
  • Therapy
  • United States
  • BeiGene, Ltd.
View report >

Lymphoma Statistics in the UK and France

  • June 2019
  • 17 pages

FL, FOLLICULAR LYMPHOMA; IWG-NHL 2007, INTERNATIONAL WORKING GROUP CRITERIA FOR NON-HODGKIN' S LYMPHOMA.

  • Cancer
  • Lymphoma
  • Pathology
  • France
  • United Kingdom
View report >

Lymphoma Statistics

  • December 2019
  • 13 pages

Survival of patients with Mantle cell lymphoma by sex.

  • Cancer
  • Lymphoma
  • Pathology
  • Germany
  • United States
View report >

Lymphoma Statistics in the US

  • July 2017
  • 9 pages

These include studies in patients with relapsed or refractory Hodgkin lymphoma and CD##-expressing relapsed or refractory non-Hodgkin lymphomas, including T-cell lymphomas, diffuse large B-cell lymphoma (DLBCL), and other rare subtypes of Bcell malignancies, including mediastinal B-cell

  • Lymphoma
  • United States
  • Immunomedics, Inc.
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited
View report >

Lymphoma Statistics and Therapy Market in the US - Forecast

  • July 2017
  • 8 pages

The company intends to initiate new combination study in patients with follicular lymphoma in 2017.

  • Lymphoma
  • Therapy
  • United States
  • Epizyme, Inc.
  • GlaxoSmithKline plc
View report >

Lymphoma Statistics in Japan - Forecast

  • April 2019
  • 19 pages

In the case of Japanese patients, malignant lymphomas are mostly (##%) of the NHL type.

  • Lymphoma
  • Japan
  • Astellas Pharma Inc.
  • Onconova Therapeutics, Inc.
  • SymBio Pharmaceuticals Limited
View report >

Global Cancer Statistics

  • September 2020
  • 12 pages

In oncology, two chimeric antigen receptor T (CAR-T) cell therapies, Kymriah and Yescarta, were approved in acute lymphocytic leukemia (ALL) and diffuse large B-cell lymphoma (DLBCL) with unprecedented efficacy.

  • Cancer
  • Lymphoma
  • Pathology
  • World
  • Demand
View report >

Medical Biotechnology Industry in Canada

  • August 2019
  • 76 pages

Lymphoma Canada is Canada' s only national organization focused entirely on lymphoma.

  • Immunotherapy
  • Lymphoma
  • Medical Biotechnology
  • Therapy
  • Canada
View report >

Lymphoma Statistics in the US

  • December 2018
  • 30 pages

Abstract ##, ASH 2018 * ORR - Overall Response Rate; CR - Complete Response; PR - Partial Response; SD - Stable Disease; PD - Progressive Disease ** MCL - Mantle Cell Lymphoma - SLL Small Lymphocytic Lymphoma Highly active in advanced follicular lymphoma and in FL patien

  • Cancer
  • Immunotherapy
  • Lymphoma
  • Monoclonal Antibody
  • United States
View report >

Hospital Forecast Statistics in the US

  • December 2017
  • 34 pages

GOV CHART ##: LYMPHOMA & NON-ACUTE LEUKEMIA W/ MAJOR COMPLICATIONS OR COMORBIDITIES CHART ##: LYMPHOMA & NON-ACUTE LEUKEMIA W/ MAJOR COMPLICATIONS OR COMORBIDITIES (CONTINUED) CHART ##: LYMPHOMA & NON-ACUTE LEUKEMIA W/ COMPLICATION OR COMORBIDITI

  • Hospital
  • Lymphoma
  • United States
  • Gilead Sciences, Inc.
  • Jefferies LLC
View report >

Lymphoma Statistics in the US

  • January 2018
  • 34 pages

**Mantle cell lymphoma (n=##), marginal zone lymphoma (n=##), small lymphocytic lymphoma (SLL; n=##).

  • Cancer
  • Lymphoma
  • Pathology
  • Therapy
  • United States
View report >

Lymphoma Statistics in the US

  • January 2018
  • 13 pages

DLBCL, diffuse large B-cell lymphoma.

  • Cancer
  • Lymphoma
  • United States
  • Demographic
View report >

Medical Biotechnology Industry in Canada

  • January 2019
  • 85 pages

Lymphoma Canada is Canada' s only national organization focused entirely on lymphoma.

  • Immunotherapy
  • Lymphoma
  • Medical Biotechnology
  • Therapy
  • Canada
View report >

Hepatitis Statistics and Lymphoma Statistics in the US - Forecast

  • January 2020
  • 31 pages

lymphoma; BR = Rituxan + Bendamustine Rapid uptake in R/ R DLBCL Strong efficacy: only agent in R/ R DLBCL with OS benefit Well tolerated: combines with standard of care (BR); no unique safety monitoring requirements Off the shelf: readily available; administered in any oncology fac

  • Hepatitis
  • Lymphoma
  • Pathology
  • United States
  • Roche Group
View report >

Therapy Market in China

  • March 2018
  • 39 pages

According to research article " Distribution pattern of lymphoma subtypes in China: A nationwide multicenter study of ##, ## cases", DLBCL accounts for c. ##% of total lymphoma cases, while FL represents c. ##% of all lymphoma cases.

  • Lymphoma
  • Therapy
  • China
  • Sino Biopharmaceutical Limited
  • SWS Research Co., Ltd.

Global Non-Hodgkins Lymphoma Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • January 2017
  • 1 pages

Global Non-Hodgkins Lymphoma Epidemiology and Patient Flow Analysis - 2017 ##.

  • Cancer
  • Lymphoma
  • Pathology
  • World
  • Forecast

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on